Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
Abstract Aim To investigate the therapeutic effect of lenvatinib (LEN) in liver disease etiology, especially nonviral hepatocellular carcinoma (HCC). Methods and Results Sixty‐seven patients with unresectable advanced HCC (u‐HCC) treated with LEN and consisting of 26 hepatitis C virus (HCV), 19 hepa...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/db021b52981d4cb7841a5b454ff3109b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|